Peripheral Interventions in the VA Healthcare System

Slides:



Advertisements
Similar presentations
Peripheral Arterial Disease Mehul Bhatt, MD Interventional Cardiology / Vascular Medicine Athens Heart Center.
Advertisements

Peripheral Artery Occlusive Disease
Peripheral Arterial Disease :PAD. Introduction PAD caused by atherosclerotic occlusion of arteries to legs Prevalence 12% and increases to 20% if persons.
Peripheral Arterial Disease: missed opportunity for cardiovascular intervention Subhash Banerjee, MD Chief, Division of Cardiology VA North Texas Healthcare.
Peripheral Arterial Disease >Increasing Awareness >What is PAD >Risk factors >Symptoms of PAD >Screening & Treatment Options.
Advances in the Medical Management of Peripheral Arterial Disease Randall M. Zusman, MD Associate Professor of Medicine Harvard Medical School Director.
PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Evolving Strategies in the Treatment of Peripheral Vascular Disease Ravish Sachar MD, FACC Wake Heart and Vascular.
Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
Copyright © 2009, Society for Vascular Surgery ®. All rights reserved. Your Vascular Health is a Matter of Life and Limb.
Ankle Brachial Index Measurement: What is it and why measure it? Mary O’Connor Cardiovascular Medical Science Liason Bristol Myers Squibb Guinness Storehouse.
The Cramping Leg Management of peripheral vascular disease
Peripheral Vascular Disease in Cardiac Patients
Epidemiology of Peripheral Vascular Disease Sohail Ahmed School of Population and Health Sciences.
R Dhangana, TP Murphy, MJ Pencina, MB Ristuccia, JV Cerezo, D Tsai Prevalence of Low Ankle-Brachial Index, Elevated Plasma Fibrinogen and CRP Among Those.
PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.
The Diagnosis and Treatment of Peripheral Vascular Disease
Stay in Circulation Facts About Peripheral Arterial Disease (P.A.D.) A National Public Awareness Campaign from the P.A.D. Coalition and the National Heart,
PERIPHERAL VASCULAR DISEASE: A VASCULAR SURGEON’S POINT OF VIEW
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Lower Extremity Venous Disease: Peripheral Venous Insufficiency
Screening for Abdominal Aortic Aneurysm Peter D. Newcomer, MD.
Screening Guidelines and Treatment Options for Abdominal Aortic Aneurysms Allen Jeremias, MD Division of Cardiology B eth I srael D eaconess M edical C.
“Outpatient Arteriography and Arterial Intervention in Octogenarians. Is It Safe?” George G. Hartnell Baystate Medical Center Springfield, MA Safe at Any.
Management of Dyslipidemia in Patients with Peripheral Arterial Disease: an update from Guidelines Oman International Vascular Conference Al-Bustan Palace.
Peripheral Arterial Disease Education and ABI Training for Vascular Nurses Presented by The Society for Vascular Nursing Comprehensive In-Service Lecture.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Peripheral Artery Disease (PAD) & Ankle Brachial Index (ABI) Marge Lovell RN CCRC CVN BEd MEd London Health Sciences Centre London, Ontario, Canada.
What Is Peripheral Vascular Disease? Daniel B. Walsh, M.D. Professor of Surgery, Section of Vascular Surgery Vice-Chair, Department of Sugery Dartmouth-Hitchcock.
PAD AND VASCULAR EVENTS  IC AS A DISEASE OFTEN REMAINS UN RECOGNISED. AS HIGH AS 75% OF PEOPLE WHO HAVE IC DO NOT SEEK MEDICAL HELP SINCE MANY PEOPLE.
Aims To evaluate the technical and clinical outcome of percutaneous transluminal infra-popliteal angioplasties (PTIA) +/- stenting in a subgroup of patients.
Post-Surgical Care for the Individual With PAD: A Shared Responsibility to Sustain Life and Limb.
Are you at Risk for a Stroke, Aneurysm or Peripheral Arterial Disease?
Ross Milner, MDUniversity of Chicago Mark Russo, MD, MS Center for Aortic Diseases.
Peripheral Arterial Disease Mohammed Al-Omran, MD, MSc, FRCSC Assistant Professor & Consultant Vascular Surgery King Saud University.
Peripheral Arterial Disease in Saudi Arabia : Where Do We Stand? Mohammed Al-Omran, MD, MSc, FRCSC Associate Professor & Vascular Surgeon, King Saud University.
C. Diehm, 2007 Excess cardiovascular mortality in patients with peripheral arterial disease in primary care: 5-year results of the getABI Study Diehm C,
1 “Diabetic foot” Sensory Autonomic Motor. 2 Neuropathic: 45-60% Purely ischaemic: 10% Mixed neuroischaemic: 25-40% Diabetic foot ulceration.
VA National Center for Health Promotion and Disease Prevention Using USPSTF Recommendations in VHA Clinical Practice Linda Kinsinger, MD, MPH Chief Consultant.
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
ACC/AHA 2006 guidelines on the management of PAD.
The implement of ABI/TBI measurement system based on Zigbee technique (PART 2) Presenter: Ying-Tsung Shiau Adviser: Dr. Pei-Jarn Chen Date: 2010/11/03.
Peripheral Arterial Disease Doctor’s Name Contact Information.
Medical Management of Claudication: Just Walk it Off!!
Relative Risk vs the General Population ReducedIncreased Diabetes Smoking Hypertension Total cholesterol (10 mg/dL)
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
Incidence of Abnormal Ankle-Brachial Index in Diabetic Patients Asymptomatic of Arteriosclerotic Vascular disease Brintha Vasagar, MD, MPH, Katee Castleman,
Peripheral Vascular Disease
Peripheral Artery Disease (PAD)
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.
Abdominal Aortic Aneurysm
Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease   Debbie C. Chen1, Gagan.
Approach to CLI – Consider Arterial & Venous Insufficiency
Non Atherosclerotic Peripheral Artery Disease
CRT 2012 Venous Disease.
Complex Ostial Disease of the Aortic Arch Vessels
TAVI Passed the Exam and is Ready for Clinical Use in Inoperable Patients Disclosures Research Funding and Speaking Honoraria: Edwards Lifesciences.
NIC Kolkata 2013 Peripheral Arterial Disease: missed opportunity for cardiovascular intervention Subhash Banerjee, MD Chief, Division of Cardiology VA.
Multidisciplinary Approach for a Successful CLI Management Program
The Role of Interventional Treatment for The Failing Grafts
Single Stage CABG and Peripheral Arterial Bypass for Combined Coronary and Peripheral Arterial Disease Divya Arora, Ashok Chahal and Shamsher Singh Lohchab.
Peripheral Arterial Disease
Post-Surgical Care for the Individual With PAD
Prashant Kaul, MD, FSCAI Piedmont Heart Institute, Atlanta, GA
Webcast May 10th, 2004 Sponsored by
Gait Biomechanics in Patients with Peripheral Artery Disease After Revascularization Sarah Bakera, Sara A. Myersa,c, Iraklis Pipinosb,c, and Jason Johanningb,c.
Stay in Circulation Facts About Peripheral Arterial Disease (P.A.D.)
Division of Endovascular Interventions
Vascular Surgery Michael Ricci, MD.
Presentation transcript:

Peripheral Interventions in the VA Healthcare System Ehrin J. Armstrong MD MSc Director, Interventional Cardiology Denver VA Medical Center

Disclosures None relevant

Manifestations of Peripheral Artery Disease Lower Extremity Claudication Critical Limb Ischemia Acute Limb Ischemia Carotid Artery Stenosis Subclavian Artery Stenosis Renal Artery Stenosis Mesenteric Stenosis Abdominal Aortic Aneurysm Popliteal Artery Aneurysm

Estimates of PAD Prevalence Every patient in the VA! In a primary care population defined by age and common risk factors, the prevalence of PAD was approximately one in three patients NHANES1 Aged >40 years 4.3% San Diego2 Mean age 66 years 11.7% NHANES1 Aged 70 years 14.5% Rotterdam3 Aged >55 years 19.1% Diehm4 Aged 65 years 19.8% PARTNERS5 Aged >70 years, or 50–69 years with a history diabetes or smoking 29% PARTNERS trial showed us that many patients were not aware of the sx’s of PAD, and that routine screening, especially with ABIs can detect and treat these patients sooner. Prevalence of PAD Increases with Age 0% 5% 10% 15% 20% 25% 30% 35% NHANES=National Health and Nutrition Examination Study; PARTNERS=PAD Awareness, Risk, and Treatment: New Resources for Survival [program]. 1. Selvin E, Erlinger TP. Circulation. 2004;110:738-743. 2. Criqui MH, et al. Circulation. 1985;71:510-515. 3. Diehm C, et al. Atherosclerosis. 2004;172:95-105. 4. Meijer WT, et al. Arterioscler Thromb Vasc Biol. 1998;18:185-192. 5. Hirsch AT, et al. JAMA. 2001;286:1317-1324. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the national health and nutrition survey, 1999-2000. Circulation. 2004;110:738-743. Criqui MH, et al. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510-515. Meijer WT, et al. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 1998;18:185-192. Diehm C, et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis. 2004;172:95–105. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-1324. 4

PAD in Veterans 403 patients in Houston area over 50 years of age were screened with ABI. Prevalence was 13% among whites 22% among African Americans 14% among Hispanics Collins, Arch Int Med 2003

PAD and Survival Survival (%) Years Normal subjects Asymptomatic PAD 100 75 50 25 Normal subjects Survival (%) Asymptomatic PAD Symptomatic PAD Previous investigators have observed a doubling of the mortality rate among patients with intermittent claudication, and we have reported a fourfold increase in the overall mortality rate among subjects with large-vessel peripheral arterial disease, as diagnosed by noninvasive testing. In this study, we investigated the association of large-vessel peripheral arterial disease with rates of mortality from all cardiovascular diseases and from coronary heart disease. METHODS. We examined 565 men and women (average age, 66 years) for the presence of large-vessel peripheral arterial disease by means of two noninvasive techniques--measurement of segmental blood pressure and determination of flow velocity by Doppler ultrasound. We identified 67 subjects with the disease (11.9 percent), whom we followed prospectively for 10 years. RESULTS. Twenty-one of the 34 men (61.8 percent) and 11 of the 33 women (33.3 percent) with large-vessel peripheral arterial disease died during follow-up, as compared with 31 of the 183 men (16.9 percent) and 26 of the 225 women (11.6 percent) without evidence of peripheral arterial disease. After multivariate adjustment for age, sex, and other risk factors for cardiovascular disease, the relative risk of dying among subjects with large-vessel peripheral arterial disease as compared with those with no evidence of such disease was 3.1 (95 percent confidence interval, 1.9 to 4.9) for deaths from all causes, 5.9 (95 percent confidence interval, 3.0 to 11.4) for all deaths from cardiovascular disease, and 6.6 (95 percent confidence interval, 2.9 to 14.9) for deaths from coronary heart disease. The relative risk of death from causes other than cardiovascular disease was not significantly increased among the subjects with large-vessel peripheral arterial disease. After the exclusion of subjects who had a history of cardiovascular disease at base line, the relative risks among those with large-vessel peripheral arterial disease remained significantly elevated. Additional analyses revealed a 15-fold increase in rates of mortality due to cardiovascular disease and coronary heart disease among subjects with large-vessel peripheral arterial disease that was both severe and symptomatic. CONCLUSIONS. Patients with large-vessel peripheral arterial disease have a high risk of death from cardiovascular causes PAD is an equivalent to ischemic heart disease risk. The association between peripheral arterial disease and coronary artery disease has been known for many years Prevalence of CHD if history/physical exam is used 20%-40% Prevalence of CHD if noninvasive testing is used 50%-60% Prevalence of CHD if coronary arteriography is used ~90% Dormandy JA, and Murray GD. Eur J Vasc Surg. 1991;5(2):131-133. Severe symptomatic PAD 2 4 6 8 10 12 Years Criqui MH et al. N Engl J Med. 1992;326:381-386. 6

Vascular Medicine at Denver VA Claudication Critical Limb Ischemia Acute Limb Ischemia Carotid Artery Stenosis Subclavian Artery Stenosis Renal Artery Stenosis Mesenteric Ischemia Abdominal Aortic Aneurysm Popliteal Artery Aneurysm DVT/PE e.g., IVC filters Vasculitis Fibromuscular Dysplasia

What We Do Inpatient Consultation Outpatient Consultation About 2-3/week Outpatient Consultation Three clinics a week: see 40-50 patients weekly Dedicate vascular NP Vascular Noninvasive Studies One vascular tech 1600 studies/year Endovascular Procedures Mix of LE, carotid, and AAA interventions 350-400 cases/year

Placing an Outpatient Vascular Medicine Consult

Placing an Outpatient Vascular Medicine Consult

Ordering Vascular Lab Studies

Vascular Imaging Options

Arterial Imaging Examples

Case: Claudication 64M with PMH of prior smoking, hypercholesterolemia p/w calf pain on ambulation. Pain is bilateral, but left worse than right. Claudication begins at 100 yards, has to stop walking at 200 years. Tried a walking program x 6 months, but remains severely impaired in daily activities.

Follow-Up Patient went home later that day. No more claudication Have been following last 3.5 years – patent vessels, no symptoms.

Case: Critical Limb Ischemia 61 woman with ischemic rest pain and worsening necrotic ulcers on the medial and lateral aspect of the left lower leg CAD with h/o 2 vessel CABG in 2003 and recent stenting On hemodialysis No usable saphenous or arm vein

Arterial Ulcer

Follow Up No further rest pain. Ulcers healed. Duplex ultrasound: wide patency of popliteal artery stent, TP trunk, and peroneal artery.

Case: AAA 67M with 6.0 cm infrarenal AAA and severe R>L claudication. Concomitant R CIA aneurysm (30 mm). Occluded R EIA artery.

Credentialing Every VA hospital has a different credentialing system. All politics are local. Work with administration to ensure you are covered.

Opportunities for Advancing the Care of Veterans with PAD More research on prevalence and outcomes of Veterans with PAD Optimal medical therapy Smoking cessation programs Integrated CART-peripheral Defined data elements Amputation prevention programs Centers of excellence? Multidisciplinary coordination